These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 14599482)

  • 61. Ibotenic acid lesion of nucleus basalis magnocellularis differentially affects cholinergic, glutamatergic and GABAergic markers in cortical rat brain regions.
    Rossner S; Schliebs R; Bigl V
    Brain Res; 1994 Dec; 668(1-2):85-99. PubMed ID: 7704621
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Plaque-associated overexpression of insulin-degrading enzyme in the cerebral cortex of aged transgenic tg2576 mice with Alzheimer pathology.
    Leal MC; Dorfman VB; Gamba AF; Frangione B; Wisniewski T; Castaño EM; Sigurdsson EM; Morelli L
    J Neuropathol Exp Neurol; 2006 Oct; 65(10):976-87. PubMed ID: 17021402
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Probing amyloid-β pathology in transgenic Alzheimer's disease (tgArcSwe) mice using MALDI imaging mass spectrometry.
    Carlred L; Michno W; Kaya I; Sjövall P; Syvänen S; Hanrieder J
    J Neurochem; 2016 Aug; 138(3):469-78. PubMed ID: 27115712
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Neuronal amyloid-β accumulation within cholinergic basal forebrain in ageing and Alzheimer's disease.
    Baker-Nigh A; Vahedi S; Davis EG; Weintraub S; Bigio EH; Klein WL; Geula C
    Brain; 2015 Jun; 138(Pt 6):1722-37. PubMed ID: 25732182
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Changes in the brain and plasma Aβ peptide levels with age and its relationship with cognitive impairment in the APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Izco M; Martínez P; Corrales A; Fandos N; García S; Insua D; Montañes M; Pérez-Grijalba V; Rueda N; Vidal V; Martínez-Cué C; Pesini P; Sarasa M
    Neuroscience; 2014 Mar; 263():269-79. PubMed ID: 24447596
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Transgenic mice as a model of pre-clinical Alzheimer's disease.
    Ferretti MT; Partridge V; Leon WC; Canneva F; Allard S; Arvanitis DN; Vercauteren F; Houle D; Ducatenzeiler A; Klein WL; Glabe CG; Szyf M; Cuello AC
    Curr Alzheimer Res; 2011 Feb; 8(1):4-23. PubMed ID: 21143159
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Quantitative Comparison of Dense-Core Amyloid Plaque Accumulation in Amyloid-β Protein Precursor Transgenic Mice.
    Liu P; Reichl JH; Rao ER; McNellis BM; Huang ES; Hemmy LS; Forster CL; Kuskowski MA; Borchelt DR; Vassar R; Ashe KH; Zahs KR
    J Alzheimers Dis; 2017; 56(2):743-761. PubMed ID: 28059792
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Sleep and circadian abnormalities in a transgenic mouse model of Alzheimer's disease: a role for cholinergic transmission.
    Wisor JP; Edgar DM; Yesavage J; Ryan HS; McCormick CM; Lapustea N; Murphy GM
    Neuroscience; 2005; 131(2):375-85. PubMed ID: 15708480
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The evolution of A beta peptide burden in the APP23 transgenic mice: implications for A beta deposition in Alzheimer disease.
    Kuo YM; Beach TG; Sue LI; Scott S; Layne KJ; Kokjohn TA; Kalback WM; Luehrs DC; Vishnivetskaya TA; Abramowski D; Sturchler-Pierrat C; Staufenbiel M; Weller RO; Roher AE
    Mol Med; 2001 Sep; 7(9):609-18. PubMed ID: 11778650
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Differential alteration of various cholinergic markers in cortical and subcortical regions of human brain in Alzheimer's disease.
    Araujo DM; Lapchak PA; Robitaille Y; Gauthier S; Quirion R
    J Neurochem; 1988 Jun; 50(6):1914-23. PubMed ID: 3373218
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Oral Administration of Gintonin Attenuates Cholinergic Impairments by Scopolamine, Amyloid-β Protein, and Mouse Model of Alzheimer's Disease.
    Kim HJ; Shin EJ; Lee BH; Choi SH; Jung SW; Cho IH; Hwang SH; Kim JY; Han JS; Chung C; Jang CG; Rhim H; Kim HC; Nah SY
    Mol Cells; 2015 Sep; 38(9):796-805. PubMed ID: 26255830
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Alterations in α4β2 nicotinic receptors in cognitive decline in Alzheimer's aetiopathology.
    Okada H; Ouchi Y; Ogawa M; Futatsubashi M; Saito Y; Yoshikawa E; Terada T; Oboshi Y; Tsukada H; Ueki T; Watanabe M; Yamashita T; Magata Y
    Brain; 2013 Oct; 136(Pt 10):3004-17. PubMed ID: 23975517
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Elevated A beta and apolipoprotein E in A betaPP transgenic mice and its relationship to amyloid accumulation in Alzheimer's disease.
    Kuo YM; Crawford F; Mullan M; Kokjohn TA; Emmerling MR; Weller RO; Roher AE
    Mol Med; 2000 May; 6(5):430-9. PubMed ID: 10952022
    [TBL] [Abstract][Full Text] [Related]  

  • 74. 192IgG-saporin-induced immunotoxic lesions of cholinergic basal forebrain system differentially affect glutamatergic and GABAergic markers in cortical rat brain regions.
    Rossner S; Schliebs R; Bigl V
    Brain Res; 1995 Oct; 696(1-2):165-76. PubMed ID: 8574666
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Acetylcholinesterase promotes beta-amyloid plaques in cerebral cortex.
    Rees T; Hammond PI; Soreq H; Younkin S; Brimijoin S
    Neurobiol Aging; 2003 Oct; 24(6):777-87. PubMed ID: 12927760
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Peripheral treatment with enoxaparin exacerbates amyloid plaque pathology in Tg2576 mice.
    Cui H; King AE; Jacobson GA; Small DH
    J Neurosci Res; 2017 Apr; 95(4):992-999. PubMed ID: 27546887
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Abeta-degrading endopeptidase, neprilysin, in mouse brain: synaptic and axonal localization inversely correlating with Abeta pathology.
    Fukami S; Watanabe K; Iwata N; Haraoka J; Lu B; Gerard NP; Gerard C; Fraser P; Westaway D; St George-Hyslop P; Saido TC
    Neurosci Res; 2002 May; 43(1):39-56. PubMed ID: 12074840
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Apolipoprotein E deposition and astrogliosis are associated with maturation of beta-amyloid plaques in betaAPPswe transgenic mouse: Implications for the pathogenesis of Alzheimer's disease.
    Terai K; Iwai A; Kawabata S; Sasamata M; Miyata K; Yamaguchi T
    Brain Res; 2001 May; 900(1):48-56. PubMed ID: 11325345
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Intraneuronal Abeta accumulation precedes plaque formation in beta-amyloid precursor protein and presenilin-1 double-transgenic mice.
    Wirths O; Multhaup G; Czech C; Blanchard V; Moussaoui S; Tremp G; Pradier L; Beyreuther K; Bayer TA
    Neurosci Lett; 2001 Jun; 306(1-2):116-20. PubMed ID: 11403971
    [TBL] [Abstract][Full Text] [Related]  

  • 80. High tryptophan diet reduces CA1 intraneuronal β-amyloid in the triple transgenic mouse model of Alzheimer's disease.
    Noristani HN; Verkhratsky A; Rodríguez JJ
    Aging Cell; 2012 Oct; 11(5):810-22. PubMed ID: 22702392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.